Literature DB >> 9856561

Mutation analysis of Gaucher disease patients from Argentina: high prevalence of the RecNciI mutation.

B Cormand1, T L Harboe, L Gort, C Campoy, M Blanco, N Chamoles, A Chabás, L Vilageliu, D Grinberg.   

Abstract

Gaucher disease (GD) is caused by a deficiency of beta-glucocerebrosidase activity mainly due to mutations in the gene coding for the enzyme. More than 100 mutations have been identified to date and their frequencies have been established in several populations, including Ashkenazi Jews, among whom the disease is particularly prevalent. In order to study the molecular pathology of the disease in patients from Argentina, we conducted a systematic search for mutations in the glucocerebrosidase gene. Genomic DNA from 31 unrelated GD patients was screened for seven previously described mutations: N370S (1226A-->G), L444P (1448T-->C), D409H (1342G-->C), R463C (1504C-->T), 1263de155, RecNciI, and RecTL. This allowed the identification of 77.4% of the GD alleles: N370S and RecNciI were the most prevalent mutations found (46.8% and 21% respectively). Southern analysis demonstrated three distinct patterns for the RecNciI alleles. In order to identify the remaining alleles, the full coding region of the gene, all the splice sites, and part of the promoter region were analyzed by single-strand conformational polymorphism analysis (SSCP) after polymerase chain reaction amplification. This extensive screening allowed the identification of 13 different mutations, accounting for 93% of the total number of GD alleles. Three novel missense mutations, I161S (599T-->G), G265D (911G-->A), and F411I (1348T-->A), were detected. Twelve polymorphic sites within the glucocerebrosidase gene are in complete linkage disequilibrium and define two major haplotypes, "-" and "+". Mutation N370S was always associated with the "-" haplotype, as described in other populations. Interestingly, the RecNciI alleles with the same Southern-blot pattern were always associated with the same haplotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856561     DOI: 10.1002/(sici)1096-8628(19981204)80:4<343::aid-ajmg8>3.0.co;2-w

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Gene rearrangements in the glucocerebrosidase-metaxin region giving rise to disease-causing mutations and polymorphisms. Analysis of 25 Rec NciI alleles in Gaucher disease patients.

Authors:  Anna Díaz-Font; Bru Cormand; Mariana Blanco; Néstor Chamoles; Amparo Chabás; Daniel Grinberg; Lluïsa Vilageliu
Journal:  Hum Genet       Date:  2003-02-14       Impact factor: 4.132

2.  Glucosidase acid beta gene mutations in Egyptian children with Gaucher disease and relation to disease phenotypes.

Authors:  Zakarya El-Morsy; Mohamed T Khashaba; Othman El-Sayed Soliman; Sohier Yahia; Dina Abd El-Hady
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

3.  Neonatal cholestasis as initial manifestation of type 2 Gaucher disease: a continuum in the spectrum of early onset Gaucher disease.

Authors:  Abdallah F Elias; Maria Ronningen Johnson; John K Boitnott; David Valle
Journal:  JIMD Rep       Date:  2011-12-11

4.  GBA mutations in Gaucher type I Venezuelan patients: ethnic origins and frequencies.

Authors:  Gilberto Gómez; Sergio Arias; Leonor Cárdenas; Dalal Zoghbi; Irene Paradisi
Journal:  J Genet       Date:  2017-09       Impact factor: 1.166

5.  Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.

Authors:  Leelamma M Panicker; Diana Miller; Ola Awad; Vivek Bose; Yu Lun; Tea Soon Park; Elias T Zambidis; Judi A Sgambato; Ricardo A Feldman
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

6.  Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2.

Authors:  Friederike Zunke; Lisa Andresen; Sophia Wesseler; Johann Groth; Philipp Arnold; Michelle Rothaug; Joseph R Mazzulli; Dimitri Krainc; Judith Blanz; Paul Saftig; Michael Schwake
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

7.  Long-read single molecule real-time (SMRT) sequencing of GBA1 locus in Gaucher disease national cohort from Argentina reveals high frequency of complex allele underlying severe skeletal phenotypes: Collaborative study from the Argentine Group for Diagnosis and Treatment of Gaucher Disease.

Authors:  Guillermo I Drelichman; Nicolas Fernández Escobar; Barbara C Soberon; Nora F Basack; Joaquin Frabasil; Andrea B Schenone; Gabriel Aguilar; Maria S Larroudé; James R Knight; Dejian Zhao; Jiapeng Ruan; Pramod K Mistry
Journal:  Mol Genet Metab Rep       Date:  2021-11-11

8.  Gaucher disease in Syrian children: common mutations identification, and clinical futures.

Authors:  Diana Alasmar
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

9.  Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece.

Authors:  Evangelia Dimitriou; Marina Moraitou; Mónica Cozar; Jenny Serra-Vinardell; Lluïsa Vilageliu; Daniel Grinberg; Irene Mavridou; Helen Michelakakis
Journal:  Mol Genet Metab Rep       Date:  2020-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.